Olga Kantor

Jun 14, 2023 | jamanetwork.com | Olga Kantor |Rachel A. Freedman |Erica L. Mayer |Mariana Chavez- MacGregor

Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor–Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial Key PointsQuestion  Are there differences in locoregional recurrence by race and ethnicity among patients with hormone receptor–positive, node-negative, early-stage breast cancer?

Apr 12, 2023 | jamanetwork.com | Olga Kantor |Rachel A. Freedman |Erica L. Mayer |Mariana Chavez- MacGregor

Key PointsQuestion  Are there differences in locoregional recurrence by race and ethnicity among patients with hormone receptor–positive, node-negative, early-stage breast cancer? Findings  In this post hoc analysis of 9369 randomized clinical trial participants, 8-year rates of breast cancer locoregional recurrence were highest among Asian and non-Hispanic Black women (4%) compared with Hispanic (3%) and non-Hispanic White women (2%).